167 related articles for article (PubMed ID: 30326857)
1. Estrogen receptor β is associated with expression of cancer associated genes and survival in ovarian cancer.
Schüler-Toprak S; Weber F; Skrzypczak M; Ortmann O; Treeck O
BMC Cancer; 2018 Oct; 18(1):981. PubMed ID: 30326857
[TBL] [Abstract][Full Text] [Related]
2. The expression and correlation between the transcription factor FOXP1 and estrogen receptors in epithelial ovarian cancer.
Hu Z; Zhu L; Tan M; Cai M; Deng L; Yu G; Liu D; Liu J; Lin B
Biochimie; 2015 Feb; 109():42-8. PubMed ID: 25500588
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer.
De Stefano I; Zannoni GF; Prisco MG; Fagotti A; Tortorella L; Vizzielli G; Mencaglia L; Scambia G; Gallo D
Gynecol Oncol; 2011 Sep; 122(3):573-9. PubMed ID: 21665249
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of the estrogen receptor beta (ERβ) isoforms ERβ1, ERβ2, and ERβ5 in advanced serous ovarian cancer.
Ciucci A; Zannoni GF; Travaglia D; Petrillo M; Scambia G; Gallo D
Gynecol Oncol; 2014 Feb; 132(2):351-9. PubMed ID: 24378878
[TBL] [Abstract][Full Text] [Related]
5. Regulation of semaphorin 4D expression and cell proliferation of ovarian cancer by ERalpha and ERbeta.
Liu Y; Hou Y; Ma L; Sun C; Pan J; Yang Y; Zhou H; Zhang J
Braz J Med Biol Res; 2017 Feb; 50(3):e6057. PubMed ID: 28225892
[TBL] [Abstract][Full Text] [Related]
6. Expression of estrogen-responsive finger protein (Efp) is associated with advanced disease in human epithelial ovarian cancer.
Sakuma M; Akahira J; Suzuki T; Inoue S; Ito K; Moriya T; Sasano H; Okamura K; Yaegashi N
Gynecol Oncol; 2005 Dec; 99(3):664-70. PubMed ID: 16140366
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
8. Involvement of estrogen receptor beta in ovarian carcinogenesis.
Bardin A; Hoffmann P; Boulle N; Katsaros D; Vignon F; Pujol P; Lazennec G
Cancer Res; 2004 Aug; 64(16):5861-9. PubMed ID: 15313930
[TBL] [Abstract][Full Text] [Related]
9. PES1 differentially regulates the expression of ERα and ERβ in ovarian cancer.
Li J; Zhuang Q; Lan X; Zeng G; Jiang X; Huang Z
IUBMB Life; 2013 Dec; 65(12):1017-25. PubMed ID: 24376209
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer.
Aust S; Horak P; Pils D; Pils S; Grimm C; Horvat R; Tong D; Schmid B; Speiser P; Reinthaller A; Polterauer S
BMC Cancer; 2013 Mar; 13():115. PubMed ID: 23497172
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of ERα, ERβ, and TFF1 in type I and II ovarian tumors.
Abdou AG; Aiad HA; Asaad NY; Abd El-Wahed MM; Serag El-Dien M
Appl Immunohistochem Mol Morphol; 2014 Jul; 22(6):421-32. PubMed ID: 24162262
[TBL] [Abstract][Full Text] [Related]
12. Significance of ERβ expression in different molecular subtypes of breast cancer.
Guo L; Meng J; Yilamu D; Jakulin A; Fu M; Wang B; Abulajiang G
Diagn Pathol; 2014 Jan; 9():20. PubMed ID: 24457087
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX
Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193
[TBL] [Abstract][Full Text] [Related]
14. Absence of estrogen receptor-beta expression in metastatic ovarian cancer.
Rutherford T; Brown WD; Sapi E; Aschkenazi S; Muñoz A; Mor G
Obstet Gynecol; 2000 Sep; 96(3):417-21. PubMed ID: 10960636
[TBL] [Abstract][Full Text] [Related]
15. Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cells.
Schüler-Toprak S; Moehle C; Skrzypczak M; Ortmann O; Treeck O
BMC Cancer; 2017 May; 17(1):319. PubMed ID: 28482871
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma.
Gruvberger-Saal SK; Bendahl PO; Saal LH; Laakso M; Hegardt C; Edén P; Peterson C; Malmström P; Isola J; Borg A; Fernö M
Clin Cancer Res; 2007 Apr; 13(7):1987-94. PubMed ID: 17404078
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor subtypes in ovarian cancer: a clinical correlation.
Chan KK; Wei N; Liu SS; Xiao-Yun L; Cheung AN; Ngan HY
Obstet Gynecol; 2008 Jan; 111(1):144-51. PubMed ID: 18165403
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor beta (ERbeta) protein expression correlates with BAG-1 and prognosis in brain glial tumours.
Batistatou A; Kyzas PA; Goussia A; Arkoumani E; Voulgaris S; Polyzoidis K; Agnantis NJ; Stefanou D
J Neurooncol; 2006 Mar; 77(1):17-23. PubMed ID: 16292491
[TBL] [Abstract][Full Text] [Related]
19. [Influence of gonadotropin-releasing hormone agonist on the effects of chemotherapy upon ovarian cancer: an experimental study with rat model].
Yuan GW; Shen K; Yang JX
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1428-31. PubMed ID: 16029659
[TBL] [Abstract][Full Text] [Related]
20. Investigation of immunohistochemical ERα, ERβ and ERβcx expressions in normal and neoplastic breast tissues.
Bozkurt KK; Kapucuoğlu N
Pathol Res Pract; 2012 Mar; 208(3):133-9. PubMed ID: 22336175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]